By Katie Reid ZURICH, Jan 31 (Reuters) – Novartis AG’s (NOVN.VX) vaccine against meningococcal disease, a cause of potentially deadly meningitis, failed to get U.S. backing for use in infants between two months and 12 months of age, the Swiss drugmaker said. The news comes as a setback for Novartis’s meningitis franchise as its Vaccines […]
Genetic differences that make some people susceptible to meningitis revealed in major new study
By: Laura Gallagher Originally posted on 08 August 2010 Genetic differences that make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune, are revealed in a new study of over 6,000 people, published today in Nature Genetics. The research, led by Imperial College London and the Genome Institute of Singapore, is […]
